FDA Drug Recalls

Recalls / Class II

Class IID-1265-2016

Product

Epinephrine 100mcg/mL injection in 0.9% Sodium Chloride 10 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0120-72

Affected lot / code info
All Sterile Compounded Products within Expiry

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Pharmakon Pharmaceuticals, Inc.
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
14450 Getz Rd, Noblesville, Indiana 46060-3303

Distribution

Quantity
280
Distribution pattern
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

Timeline

Recall initiated
2016-04-20
FDA classified
2016-07-11
Posted by FDA
2016-07-20
Terminated
2018-01-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1265-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls